The tiny startups and small caps that we invest in have just dodged a bullet.
Because American consumers are free to buy the health care they want, they currently fund most of the world’s medical innovations. Those innovations are not, by the way, coming from Big Pharma. Like any established industry, Big Pharma resists change and protects the status quo.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
- 4 views
Reactions to How Breakthrough Medical Technology Investors Dodged a Bullet
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account